MANUFACTURE OF OPTICALLY ACTIVE OR RACEMIC PROSTAGLANDIN OR PHARMACOLOGICALLY ACCEPTABLE SALTS

摘要

omega -Nor-cycloalkyl-13,14-dehydro-prostaglandin compounds, specifically 5c-9-oxo-11 alpha ,15S-dihydroxy-20,19,18-tirnor-17-cyclohexyl-prost-5-en-13-ynoic acid, the esters and salts thereof, having antiulcer and luteolytic activity, are disclosed.